Detection of thyroid peroxidase mRNA and protein in orbital tissue

European Journal of Endocrinology

Volumn 155, Issue 2, 2006, Pages 213-218

  Lai, Oi Fah ^a   Zaiden, Norazean ^a   Goh, Sui Sin ^a   Mohamed, Nur Ezan ^a   Seah, Lay Leng ^b   Fong, Kee Siew ^b   Estienne, Valerie ^c   Carayon, Pierre ^c   Ho, Su Chin ^a   Khoo, Daphne H C ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; THYROID PEROXIDASE;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; EYELID RECONSTRUCTION; FIBROBLAST; FIBROBLAST CULTURE; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOMODULATION; ORBIT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; WESTERN BLOTTING;

ADIPOCYTES; ADIPOSE TISSUE; BLOTTING, WESTERN; CELLS, CULTURED; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GRAVES OPHTHALMOPATHY; HUMANS; IODIDE PEROXIDASE; ORBIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33747656341     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02205     Document Type: Article

References (29)

1. Hunt NS, Willey KP, Jahner D, Ivell R, Northemann W, Castel MA & Leidenberger F. Multiple forms of thyroid stimulating hormone receptor associated with Graves' disease. Experimental and Clinical Endocrinology 1992 100 22-27.
2. Ludgate ME. Animal models of thyroid-associated ophthalmopathy. Thyroid 2002 12 205-208.
3. Baker G, Mazziotti G, von Ruldand C & Ludgate M. Reevaluating thyrotropin receptor based mouse models of Graves' disease and ophthalmopathy. Endocrinology 2005 146 835-844.
4. Yamada M, Li AW, West KA, Chang CH & Wall JR. Experimental model for ophthalmopathy in BALB/c and outbred (CD-1) mice genetically immunized with G2s and thyrotropin receptor. Autoimmunity 2002 35 403-413.
5. Murakami M, Miyashita K, Yamada M, Iriuchijima T & Mori M. Charaterization of human tyrotropin receptor-related peptide-like immunoreactivity in peripheral blood of Graves' disease. Biochemical Biophysical Research Communications 1992 186 1074-1080.
6. Rapoport B, Chazenbalk GD, Jaume JC & McLachlan SM. The thyrotropin (TSH) receptor: Interaction with TSH and Autoanti-bodies. Endocrinology Reviews 1998 19 673-716.
7. Khoo DH, Ho SC, Seah LL, Fong KS, Tai ES, Chee SP, Eng PHK, Aw SE & Fok ACK. The combination of absent thyroid peroxidase antibodies and high thyroid stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy. Thyroid 1999 9 1175-1180.
8. Student AK, Hsu RY & Lane MD. Induction of fatty acid synthesis in differentiating 3T3-L1 preadipocytes. Journal of Biological Chemistry 1980 255 4745-4750.
9. Ramirez-Zacarias JL, Castro-Munozeldo F & Kuri-Harcuch W Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil Red O. Histochemistry 1992 97 493-497.
10. Wall JR. Graves' disease is a multi-system autoinumme disorder in which extra ocular muscle damage and connective tissue inflammation are variable. Thyroid 2002 1 35-36.
11. Wiersinga W. Prediction and prevention of autoimmune thyroid disease. Endocrine Abstracts 2004 7 S2. 23rd joint meeting of the British Endocrine Societies with European Federation of Endocrine Societies, Brighton, UK 22-24 March.
12. Zophel K, Saller B, Wunderlich G, Gruning T, Koch R, Wilde J, Mann K & Franke W-G. Autoantibodies to thyroperoxidase(TPOAb) in a large population of euthyroid subjects: implications for the definition of TPOAb reference intervals. Clinical Laboratory 2003 49 591-600.
13. Pop VJ, Maartens LH, Leusinic G, von Son MJ, Knottneruis AA, Ward AM, Metcalfe R & Weetman AP. Are autoimmune thyroid dysfunction and depression related? Journal of Clinical Endocrinology and Metabolism 1998 83 3194-3197.
14. Poppe K, Glinoer D, Van Steirteghem A, Tournaye H, Devroey P, Schiettecatte J & Velkeniers B. Thyroid dysfunction and autoimmunity in infertile women. Thyroid 2002 12 997-1001.
15. Becker H, Hofmann M, von Einsiedel H, Conrad B & Sander D. Circumscribed vasculitis with posterior infarct in Hashimoto's encephalitis. German Nervenarzt 2002 73 376-379.
16. Smyth PPA, Schering SG, Kilbane MT, Murray MJ, McDermott EWM, Smith DF & O'Higgins NJ. Serum thyroid peroxidase autoantibodies, thyroid volume and outcome in breast carcinoma. Journal of Clinical Endocrinology and Metabolism 2002 83 2711-2716.
17. Guo J, McLachlan SM & Rapoport B. Localisation of thyroid peroxidase autoantibody immunodominant region to a junctional region containing portions of domains homologous to complement control protein and myeloperoxidase. Journal of Biological Chemistry 2002 277 40189-40195.
18. Maastricht JM, Koenig RJ, Kaplan MM, Arscott P, Thomson N & Baker JR. Identification of localised autoantibody epitopes in thyroid peroxidase. Journal of Clinical Endocrinology and Metabolism 1991 75 121-125.
19. Hayakawa K, Asano M, Shinton SA, Gui M, Wen LJ, Dashoff J & Hardy RR. Positive selection of anti-Thy 1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development. Journal of Experimental Medicine 2003 197 87-99.
20. Hardy RR, Wei CJ & Hayakawa K. Selection during development of VH11+B cells: a model for natural autoantibody -producing CD5+B cell. Immunological Reviews 2004 197 61-74.
21. Prabhakar BS, Bahn RS & Smith TJ. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocrine reviews 2003 24 802-835.
22. Rapoport B & McLachlan SM. Thyroid autoimmunity. Journal of Clinical Investigation 2001 108 1253-1259.
23. Weetman AP. Determinants of autoimmune thyroid disease. Nature Immunology 2001 2 769-770.
24. Elisei R, Vassart G & Ludgate M. Demonstration of the alternatively spliced form of thyroid peroxidase in normal thyroid. Journal of Clinical Endocrinolgy and Metabolism 1991 72 700-702.
25. Niccoli F, Fayadat L, Panneels V, Lanet J & Franc JL. Human thyroperoxidase in its alternatively spliced form (TPO 2) is enzymatically inactive and exhibits changes in intracellular processing and trafficking. Journal of Biological Chemistry 1997 272 29487-29492.
26. Ferrand M, LeFourn V & Franc JL. Increasing diversity of thyroperoxidase generated by alternative splicing. Journal of Biological Chemistry 2003 278 3793-3800.
27. Wolfram-Gabel R & Kahn JL. Adipose body of the orbit. Clinical Anatomy 2002 15 186-192.
28. Valyasevi RW, Jyonouchi SC, Dutton CM, Munsakul N & Bahn RS. The effect of tumor necrosis factor-alpha, interferon gamma and transforming growth factor-beta on adipogenesis and expression of thyrotrophin receptor in human orbital preadipocyte fibroblasts. Journal of Clinical Endocrinology and Metabolism 2001 86 501-503.
29. Kumar S, Coenen MJ, Scherer PE & Bahn RS. Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism 2004 89 930-935.